Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Revenue by Segment

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Pharmaceuticals	2.08B	1.36B	1.01B	1.11B	1.06B
Total	2.08B	1.36B	1.01B	1.11B	1.06B

Revenue by Geography

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Egypt	1.86B	1.25B	896.12M	-	-
Sudan	33.98M	30.37M	19.22M	-	-
Jordan	21.06M	13.92M	7.44M	-	-
Yemen	42.16M	20.39M	23.86M	-	-
Iraq	62.93M	12.41M	34.18M	-	-
Djibouti	265.65K	371.51K	-	-	-
Somalia	13.51M	6.75M	9.76M	-	-
South Sudan	737.75K	560.57K	452.71K	-	-
Mali	-	790.50K	262.40K	-	-
Libya	43.31M	12.82M	7.23M	-	-
Nigeria	676.48K	1.40M	-	-	-
Senegal	-	3.40M	1.68M	-	-
Kenya	-	-	122.06K	-	-
Zimbabwe	-	-	1.54M	-	-
Total	2.07B	1.36B	1.00B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error